You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

BRCA1 mutation carrier

Showing 1 - 25 of 3,315
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

BRCA1 Mutation Carrier, BRCA2 Mutation Carrier, Ductal Breast Carcinoma in Situ Trial in Los Angeles (dietary supplement, other,

Active, not recruiting
  • BRCA1 Mutation Carrier
  • +8 more
  • soy isoflavones
  • +7 more
  • Los Angeles, California
    University of Southern California
Nov 11, 2021

BRCA and NACT in TNBC Patients

Completed
  • Triple-Negative Breast Cancer
  • BRCA1/2 genetic testing
  • Rome, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 20, 2023

BRCA1/2 Flu Vaccine

Active, not recruiting
  • BRCA1 Mutation
  • BRCA2 Mutation
  • Seasonal influenza vaccine
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Aug 16, 2022

Breast Cancer, Metastatic Breast Cancer, BRCA1 Gene Mutation Trial in Boston (ABT-888, temozolomide)

Active, not recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
  • +2 more
Dec 21, 2022

Breast Cancer, Genetic Predisposition Trial in Rome, Varese (Genetic predisposition to breast cancer)

Recruiting
  • Breast Cancer
  • Genetic Predisposition
  • Genetic predisposition to breast cancer
  • Rome, Italy
  • +1 more
May 4, 2023

BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

Active, not recruiting
Has Results
  • BRCA1 Gene Mutation
  • +5 more
  • Durvalumab
  • +3 more
  • Buffalo, New York
  • +1 more
Jan 20, 2023

Endocrine Disruptors and Life STILe in Breast Cancer Development

Recruiting
  • Breast Cancer
  • +5 more
    • Roma, Italy
      Alessandra Fabi
    Feb 25, 2023

    Quality of Life Post Salpingo-oophorectomy in BRCA1/2 & PALB2

    Recruiting
    • Hereditary Breast and Ovarian Cancer
      • Barcelona, Spain
        Hospital de la Santa Creu i Sant Pau
      Jun 3, 2022

      Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)

      Not yet recruiting
      • Prostate Cancer
      • +4 more
      • (no location specified)
      Aug 10, 2022

      InheriteD brEast caNcer iTalian regIsTrY A

      Recruiting
      • Breast Cancer
        • Aviano, Pordenone, Italy
        • +11 more
        Apr 26, 2023

        Identification of a Genetic Predisposition to ProstAte Cancer

        Active, not recruiting
        • Prostate Cancer in BRCA1 and BRCA2 Carriers
        • PSA test
        • Prostate Biopsy
        • Sutton, Surrey, United Kingdom
          Cancer Genetics Unit, Royal Marsden Hospital
        Mar 30, 2022

        PREDICTION OF GERMLINE BRCA 1/2 GENES FROM HEALTHY OVARIES

        Not yet recruiting
        • BRCA Mutation
        • +2 more
        • Germinal BRCA
        • (no location specified)
        Mar 3, 2023

        Pancreatic Adenocarcinoma Metastatic, BRCA1 Mutation, BRCA2 Mutation Trial in Boston, New York (Melphalan, BCNU, Vitamin B12B)

        Recruiting
        • Pancreatic Adenocarcinoma Metastatic
        • +14 more
        • Boston, Massachusetts
        • +1 more
        Dec 6, 2022

        BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Cancer Trial in Netherlands (Salpingectomy with delayed oophorectomy,

        Active, not recruiting
        • BRCA1 Gene Mutation
        • +2 more
        • Salpingectomy with delayed oophorectomy
        • Risk-reducing salpingo-oophorectomy
        • Maastricht, Limburg, Netherlands
        • +12 more
        May 17, 2022

        Breast Cancer BRCA1 Carriers: a Pilot Study

        Withdrawn
        • BRCA1 Mutation
        • +2 more
        • Mifepristone 200 MG
        • Prophylactic mastectomy
        • Carmel, Indiana
        • +1 more
        Dec 13, 2022

        Hereditary Breast and Ovarian Cancer Trial in Cologne, Kiel, Munich (Structured exercise training plus mediterranean diet)

        Active, not recruiting
        • Hereditary Breast and Ovarian Cancer
        • Structured exercise training plus mediterranean diet
        • Cologne, Germany
        • +2 more
        Oct 25, 2022

        Women With BRCA1 Germline Deleterious Mutation Trial in France (Blood sampling)

        Completed
        • Women With BRCA1 Germline Deleterious Mutation
        • Blood sampling
        • Lyon, France
        • +3 more
        Jan 18, 2022

        Digital Genetic Counselor for BRCA1/2 Mutation Carrier Testing

        Unknown status
        • BRCA Mutations
          • (no location specified)
          Jan 29, 2020

          Metastatic Castration-resistant Prostate Cancer Trial in Guangzhou (Pamiparib)

          Recruiting
          • Metastatic Castration-resistant Prostate Cancer
          • Guangzhou, Guangdong, China
            Sun Yat-sen University Cancer Center
          Apr 7, 2022

          Breast Cancer, Ovarian Cancer, Breast Tumors Trial in Dnipro, Kyiv (Axitinib)

          Enrolling by invitation
          • Breast Cancer
          • +7 more
          • Dnipro, Ukraine
          • +1 more
          Jun 17, 2023

          Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,

          Not yet recruiting
          • Prostate Adenocarcinoma
          • +2 more
          • Biospecimen Collection
          • +6 more
          • (no location specified)
          Mar 28, 2023

          BRCA1 Mutation, BRCA2 Mutation, Ovarian Cancer Trial in Providence (Talazoparib Oral Capsule)

          Active, not recruiting
          • BRCA1 Mutation
          • +4 more
          • Talazoparib Oral Capsule
          • Providence, Rhode Island
          • +1 more
          Nov 30, 2022

          Breast Cancer, Ovarian Cancer, Pancreas Cancer Trial (TNG348, Olaparib)

          Not yet recruiting
          • Breast Cancer
          • +7 more
          • (no location specified)
          Sep 26, 2023

          Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

          Not yet recruiting
          • Metastatic Solid Tumor
          • +4 more
          • San Francisco, California
            University of California, San Francisco
          Jan 12, 2023

          BRCA1/2 Mutation Trial in Philadelphia (INO-5401, INO-9012, Cellectra 2000)

          Recruiting
          • BRCA1/2 Mutation
          • Philadelphia, Pennsylvania
            University of Pennsylvania
          Dec 7, 2021